Logo image of WEED-DB.CA

CANOPY GROWTH CORP (WEED-DB.CA) Stock Overview

Canada - TSX:WEED-DB - CA138035AC47

90 CAD
-8 (-8.16%)
Last: 9/2/2025, 7:00:00 PM
Fundamental Rating

2

Overall WEED-DB gets a fundamental rating of 2 out of 10. We evaluated WEED-DB against 35 industry peers in the Pharmaceuticals industry. WEED-DB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WEED-DB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

WEED-DB had negative earnings in the past year.
WEED-DB had a negative operating cash flow in the past year.
In the past 5 years WEED-DB always reported negative net income.
WEED-DB had a negative operating cash flow in each of the past 5 years.
WEED-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED-DB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

WEED-DB's Return On Assets of -56.65% is on the low side compared to the rest of the industry. WEED-DB is outperformed by 82.86% of its industry peers.
The Return On Equity of WEED-DB (-104.81%) is worse than 77.14% of its industry peers.
Industry RankSector Rank
ROA -56.65%
ROE -104.81%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED-DB.CA Yearly ROA, ROE, ROICWEED-DB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

WEED-DB has a worse Gross Margin (27.83%) than 65.71% of its industry peers.
WEED-DB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED-DB.CA Yearly Profit, Operating, Gross MarginsWEED-DB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

5

2. Health

2.1 Basic Checks

WEED-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WEED-DB has more shares outstanding
Compared to 5 years ago, WEED-DB has less shares outstanding
WEED-DB has a better debt/assets ratio than last year.
WEED-DB.CA Yearly Shares OutstandingWEED-DB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED-DB.CA Yearly Total Debt VS Total AssetsWEED-DB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

WEED-DB has an Altman-Z score of 21.95. This indicates that WEED-DB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of WEED-DB (21.95) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that WEED-DB is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, WEED-DB is doing worse than 62.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 21.95
ROIC/WACCN/A
WACC9.44%
WEED-DB.CA Yearly LT Debt VS Equity VS FCFWEED-DB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

WEED-DB has a Current Ratio of 3.07. This indicates that WEED-DB is financially healthy and has no problem in meeting its short term obligations.
WEED-DB has a Current ratio of 3.07. This is in the better half of the industry: WEED-DB outperforms 77.14% of its industry peers.
A Quick Ratio of 2.12 indicates that WEED-DB has no problem at all paying its short term obligations.
WEED-DB has a better Quick ratio (2.12) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 2.12
WEED-DB.CA Yearly Current Assets VS Current LiabilitesWEED-DB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

3

3. Growth

3.1 Past

WEED-DB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.18%, which is quite impressive.
WEED-DB shows a decrease in Revenue. In the last year, the revenue decreased by -4.25%.
The Revenue has been decreasing by -7.57% on average over the past years.
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%

3.2 Future

The Earnings Per Share is expected to grow by 17.25% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.90% on average over the next years.
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y23.37%
EPS Next 5Y17.25%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.04%
Revenue Next 5Y6.9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WEED-DB.CA Yearly Revenue VS EstimatesWEED-DB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
WEED-DB.CA Yearly EPS VS EstimatesWEED-DB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -20 -40 -60

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WEED-DB. In the last year negative earnings were reported.
Also next year WEED-DB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED-DB.CA Price Earnings VS Forward Price EarningsWEED-DB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED-DB.CA Per share dataWEED-DB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

WEED-DB's earnings are expected to grow with 23.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.4%
EPS Next 3Y23.37%

0

5. Dividend

5.1 Amount

No dividends for WEED-DB!.
Industry RankSector Rank
Dividend Yield N/A

CANOPY GROWTH CORP

TSX:WEED-DB (9/2/2025, 7:00:00 PM)

90

-8 (-8.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners8.19%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner ChangeN/A
Market Cap23.95B
Analysts46.15
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-99.21%
Min EPS beat(2)-206.63%
Max EPS beat(2)8.22%
EPS beat(4)1
Avg EPS beat(4)-132.67%
Min EPS beat(4)-231.12%
Max EPS beat(4)8.22%
EPS beat(8)1
Avg EPS beat(8)-186.16%
EPS beat(12)2
Avg EPS beat(12)-180.17%
EPS beat(16)4
Avg EPS beat(16)-164.19%
Revenue beat(2)2
Avg Revenue beat(2)8.61%
Min Revenue beat(2)7.65%
Max Revenue beat(2)9.57%
Revenue beat(4)3
Avg Revenue beat(4)5.74%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)9.57%
Revenue beat(8)4
Avg Revenue beat(8)-0.13%
Revenue beat(12)5
Avg Revenue beat(12)-4.62%
Revenue beat(16)6
Avg Revenue beat(16)-5.78%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)41.36%
EPS NQ rev (3m)41.36%
EPS NY rev (1m)-17%
EPS NY rev (3m)-17%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)2.72%
Revenue NY rev (1m)1.11%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 87.12
P/FCF N/A
P/OCF N/A
P/B 48.98
P/tB 67.04
EV/EBITDA N/A
EPS(TTM)-4.28
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS1.03
BVpS1.84
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.65%
ROE -104.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.83%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.16%
Cap/Sales 3.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.07
Quick Ratio 2.12
Altman-Z 21.95
F-Score5
WACC9.44%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y23.37%
EPS Next 5Y17.25%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.04%
Revenue Next 5Y6.9%
EBIT growth 1Y47.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.26%
EBIT Next 3Y32.9%
EBIT Next 5Y20.92%
FCF growth 1Y76.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.03%
OCF growth 3YN/A
OCF growth 5YN/A